These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 6575398)

  • 1. Anti-acetylcholine receptor antibodies directed against the alpha-bungarotoxin binding site induce a unique form of experimental myasthenia.
    Gomez CM; Richman DP
    Proc Natl Acad Sci U S A; 1983 Jul; 80(13):4089-93. PubMed ID: 6575398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of hyperacute experimental autoimmune myasthenia gravis. Acetylcholine receptor/cholinergic site/receptor function/autoimmunity.
    Mihovilovic M; Donnelly-Roberts D; Richman DP; Martinez-Carrion M
    J Immunol; 1994 Jun; 152(12):5997-6002. PubMed ID: 8207224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity of antibodies directed against the alpha-bungarotoxin binding site on human acetylcholine receptor and severity of myasthenia gravis.
    Vernet-der Garabedian B; Morel E; Bach JF
    J Neuroimmunol; 1986 Jul; 12(1):65-74. PubMed ID: 3711314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Heterogeneity of antibodies blocking the binding of bungarotoxin to the acetylcholine receptor in myasthenia].
    Vernet-der-Garabédian B; Morel E; Bach JF
    C R Acad Sci III; 1984; 298(16):449-56. PubMed ID: 6428718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies from myasthenic patients that compete with cholinergic agents for binding to nicotinic receptors.
    Fulpius BW; Miskin R; Reich E
    Proc Natl Acad Sci U S A; 1980 Jul; 77(7):4326-30. PubMed ID: 6933485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Search for nicotinic acetylcholine receptors on human leukocytes: absence of alpha-bungarotoxin binding in studies of healthy individuals and myasthenia gravis patients.
    Kaufman RL; Oger J
    J Neuroimmunol; 1989 Jun; 23(1):83-7. PubMed ID: 2723042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acetylcholine receptor antibody characteristics in myasthenia gravis. Fractionation of alpha-bungarotoxin binding site antibodies and their relationship to IgG subclass.
    Whiting PJ; Vincent A; Newsom-Davis J
    J Neuroimmunol; 1983 Aug; 5(1):1-9. PubMed ID: 6874919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal anti-acetylcholine-receptor antibodies directed against the cholinergic binding site.
    Mochly-Rosen D; Fuchs S
    Biochemistry; 1981 Sep; 20(20):5920-4. PubMed ID: 7295707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of sera from myasthenia gravis patients and of alpha-bungarotoxin on acetylcholinesterase during in vitro neuromuscular synaptogenesis.
    de la Porte S; Ragueh F; Eymard B; Courbin P; Chapron J; Koenig J
    J Neurol Sci; 1993 Jul; 117(1-2):92-102. PubMed ID: 8410074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of acetylcholine receptor antibodies in myasthenia gravis.
    Appel SH; Elias SB; Chauvin P
    Fed Proc; 1979 Sep; 38(10):2381-5. PubMed ID: 478014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of alpha-bungarotoxin binding to acetylcholine receptors by antisera from animals with experimental autoimmune myasthenia gravis.
    Claudio T; Raftery MA
    J Supramol Struct; 1980; 14(3):267-79. PubMed ID: 6971372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-presynaptic membrane receptor antibodies in myasthenia gravis.
    Lu CZ; Link H; Mo XA; Xiao BG; Zhang YL; Qin Z
    J Neurol Sci; 1991 Mar; 102(1):39-45. PubMed ID: 1856731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An assessment of radioimmunoassay procedures for determination of anti-acetylcholine receptor antibodies in the sera of patients with myasthenia gravis.
    Carter B; Harrison R; Lunt GG; Morris H; Savage-Marengo T; Stephenson FA
    Ann Clin Biochem; 1981 May; 18(Pt 3):146-52. PubMed ID: 7283364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myasthenia induced by monoclonal anti-acetylcholine receptor antibodies: clinical and electrophysiological aspects.
    Burres SA; Crayton JW; Gomez CM; Richman DP
    Ann Neurol; 1981 Jun; 9(6):563-8. PubMed ID: 6167199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of myasthenic immunoglobulins and cholinergic agonists on acetylcholine receptors of rat myotubes.
    Ashizawa T; Elias SB; Appel SH
    Ann Neurol; 1982 Jan; 11(1):22-7. PubMed ID: 6277235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myasthenia gravis: prototype of the antireceptor autoimmune diseases.
    Schönbeck S; Chrestel S; Hohlfeld R
    Int Rev Neurobiol; 1990; 32():175-200. PubMed ID: 1706686
    [No Abstract]   [Full Text] [Related]  

  • 17. Accelerated degradation of acetylcholine receptor from cultured rat myotubes with myasthenia gravis sera and globulins.
    Appel SH; Anwyl R; McAdams MW; Elias S
    Proc Natl Acad Sci U S A; 1977 May; 74(5):2130-4. PubMed ID: 266734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-bungarotoxin blocking antibodies in neonatal myasthenia gravis: frequency and selectivity.
    Vernet-der Garabedian B; Eymard B; Bach JF; Morel E
    J Neuroimmunol; 1989 Jan; 21(1):41-7. PubMed ID: 2908881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal anti-acetylcholine receptor antibodies as probes for human acetylcholine-receptor in myasthenia gravis.
    Vincent A; Whiting PJ; Heidenreich F; Roberts A
    J Recept Res; 1988; 8(1-4):143-59. PubMed ID: 3260283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of iodine 125 alpha-bungarotoxin to the thymus of mice.
    Ohshima F; Kondo K; Tsubaki T
    Arch Neurol; 1978 Jan; 35(1):31-2. PubMed ID: 619869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.